Medical device licence · 83833 · Class 2
MUSCLE SPECIFIC ACTIN (MSA)
No longer licensed: discontinued at renewal
Licence status Discontinued at renewal; first licensed August 31, 2010; ended September 28, 2022. It is in Health Canada’s archive of licences no longer in force.
- Licence number
- 83833
- Licence holder
- Biocare Medical, LlcPacheco, CA, United States
- Risk class
- Class II (low to moderate risk)
- Licence type
- Device Family
- First licensed
- August 31, 2010
- Ended
- September 28, 2022
- Devices covered
- 3
Devices on this licence
By name, as listed. The official record lists model numbers and identifiers.
- INTELLIPATH FLX MUSCLE SPECIFIC ACTIN (PREDILUTE MONOCLONAL ANTIBODY)
- MUSCLE SPECIFIC ACTIN (CONCENTRATE MONOCLONAL ANTIBODY)
- MUSCLE SPECIFIC ACTIN (PREDILUTE MONOCLONAL ANTIBODY)
Class I devices, the lowest-risk group, mostly need no device licence, so most are not in this list.